Study Links 2.3 Million Global Cancer Cases Annually to Infections, Emphasizing Prevention

A study published in The Lancet Oncology estimates that infections contributed to approximately 2.3 million new cancer cases globally in 2024, representing about 12% of all diagnosed cancers. The research identified 12 pathogens, including Helicobacter pylori, HPV, hepatitis B, and Epstein-Barr virus, as key contributors, underscoring the critical role of infection control and vaccination in global cancer prevention efforts.